Please login to the form below

Not currently logged in
Email:
Password:

HER2 drugs

This page shows the latest HER2 drugs news and features for those working in and with pharma, biotech and healthcare.

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination

The subcutaneous formulation of the two HER2-targeting drugs was equally as effective as giving Herceptin and Perjeta by intravenous (IV) infusion – the current route of administration – at achieving therapeutic levels ... This approval represents a

Latest news

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....